ISO IEEE 11073-40101-2022 PDF
Name in English:
St ISO IEEE 11073-40101-2022
Name in Russian:
Ст ISO IEEE 11073-40101-2022
Original standard ISO IEEE 11073-40101-2022 in PDF full version. Additional info + preview on request
Full title and description
ISO/IEEE 11073-40101:2022 — Health informatics — Device interoperability — Part 40101: Foundational — Cybersecurity — Processes for vulnerability assessment. A joint ISO/IEEE foundational standard that defines an iterative, systematic, scalable and auditable process for identifying cybersecurity vulnerabilities and estimating risk for Personal Health Devices (PHDs) and Point‑of‑Care Devices (PoCDs).
Abstract
Within the context of secure plug‑and‑play interoperability, this standard treats cybersecurity as the process and capability to prevent unauthorized access, modification, misuse, denial of use or unauthorized use of information stored on, accessed from, or transferred to/from a PHD or PoCD. It defines an iterative vulnerability‑assessment methodology using the STRIDE threat classification (Spoofing, Tampering, Repudiation, Information Disclosure, Denial of Service, Elevation of Privilege) together with an embedded Common Vulnerability Scoring System (eCVSS). The process covers system context, system decomposition, pre‑mitigation scoring, mitigation actions, post‑mitigation scoring and iteration until residual risk is reduced to an acceptable level.
General information
- Status: Published
- Publication date: 17 March 2022
- Publisher: ISO (ISO/IEEE joint standard; developed in cooperation with IEEE)
- ICS / categories: 35.240.80 (Health informatics — medical device communications)
- Edition / version: Edition 1 (2022)
- Number of pages: 38
Scope
ISO/IEEE 11073-40101:2022 applies to Personal Health Devices and Point‑of‑Care Devices in plug‑and‑play interoperability contexts. It specifies a repeatable, auditable process for threat identification and vulnerability assessment, including how to decompose device/system contexts, classify threats (STRIDE), apply eCVSS scoring before and after mitigations, and iterate risk reduction until acceptable residual risk levels are achieved. The standard is focused on the process of vulnerability assessment (not on prescribing specific cryptographic algorithms or implementation details).
Key topics and requirements
- Iterative, documented vulnerability assessment process for PHDs and PoCDs.
- Use of STRIDE threat classification to structure threat identification.
- Embedded use of Common Vulnerability Scoring (eCVSS) to rate pre‑ and post‑mitigation risk.
- System context definition and system decomposition to identify attack surfaces and trust boundaries.
- Pre‑mitigation scoring, definition and application of mitigations, followed by post‑mitigation scoring and re‑assessment.
- Scalability and auditability: process suitable for constrained devices and for regulatory or procurement evidence.
- Alignment with broader cybersecurity guidance (enabling mapping to frameworks such as NIST, ENISA, and IEC guidance through related parts of the 11073 family).
Typical use and users
Device manufacturers, firmware and software engineers, cybersecurity specialists, product security teams, systems integrators and healthcare IT architects use this standard to design, assess and document vulnerability assessment processes for interoperable personal and point‑of‑care medical devices. Regulators, conformity assessors and procurement bodies may reference the standard when evaluating device cybersecurity risk management and evidence of systematic vulnerability assessment.
Related standards
This part is one component of the ISO/IEEE 11073 device interoperability family. Closely related publications include ISO/IEEE 11073-40102:2022 (Foundational — Cybersecurity — Capabilities for mitigation) and other 11073 parts addressing personal health device communication and content models (for example parts in the 102xx and 104xx device‑specialization series and continuing updates across the 11073 family). The standard is intended to be used alongside external cybersecurity guidance such as the NIST Cybersecurity Framework, ENISA guidance and IEC TR 80001‑2‑2 where mapping to network and system risk management is needed.
Keywords
cybersecurity; vulnerability assessment; STRIDE; eCVSS; Personal Health Devices (PHD); Point‑of‑Care Devices (PoCD); device interoperability; ISO/IEEE 11073; risk assessment; mitigation; system decomposition; plug‑and‑play.
FAQ
Q: What is this standard?
A: ISO/IEEE 11073-40101:2022 is a foundational standard in the ISO/IEEE 11073 family that defines a process for cybersecurity vulnerability assessment for personal health and point‑of‑care devices.
Q: What does it cover?
A: It covers a repeatable, auditable assessment process including system context, decomposition, threat classification (STRIDE), pre‑ and post‑mitigation scoring using eCVSS, and iterative risk reduction. It focuses on process and assessment rather than prescribing implementation specifics.
Q: Who typically uses it?
A: Device manufacturers, cybersecurity engineers, product security teams, integrators, healthcare IT architects, regulators and conformity assessors who need structured vulnerability assessment and risk‑reduction evidence for interoperable medical devices.
Q: Is it current or superseded?
A: The standard was published on 17 March 2022 and is published/active. There is no indication that ISO/IEEE 11073-40101:2022 has been superseded as of 2 March 2026; users should check the ISO or IEEE catalogs for any subsequent amendments or revisions before relying on it for compliance activities.
Q: Is it part of a series?
A: Yes — it is part of the ISO/IEEE 11073 family for device interoperability. It is the foundational cybersecurity processes part and is intended to be used together with other parts (for example ISO/IEEE 11073-40102 on mitigation capabilities and other 11073 parts for communication profiles and device specializations).
Q: What are the key keywords?
A: Key keywords include cybersecurity, vulnerability assessment, STRIDE, eCVSS, device interoperability, personal health devices (PHD), point‑of‑care devices (PoCD), risk assessment and mitigation.